As global demographics change and become more diverse, limited access to new patient populations has become an increasing barrier to the development and testing of new therapies.
Genauris has taken a new approach to address this challenge, building a global network of engaged patients, community partners, and robust health data to revolutionize the reach of clinical research.
Genauris powers inclusive, efficient, and data-rich clinical trials with access to a globally diverse patient pool and tokenized real-world data. We improve recruitment, retention, and trial management – while generating real-world evidence that matters.
Through our network-based marketplace approach, Genauris is able to reach a truly broad global population – including among traditionally underserved populations.
Our platform increases patient engagement and retention compared to traditional models, offering significant improvement in study success rates. Simplified access to comprehensive patient health data and real-time outcomes reporting on our platform only further accelerates research efforts.
Our goal is to reach tens of millions of patients and thousands of practitioners and public health partners globally, with special focus on traditionally underserved communities. Genauris' first-in-kind health marketplace dramatically simplifies health interactions and incentivizes long-term participation.
As such, Genauris is building a new global ecosystem for healthcare delivery and research, backed by a comprehensive, longitudinal dataset that offers an unprecedented view into emerging global health trends.